Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY International Eye Disease Consortium. Retinal vein occlusion (RVO) guideline: executive summary. Nicholson L, Talks SJ, Amoaku W, Talks K, Sivaprasad S.
Macular grid laser photocoagulation for branch retinal vein occlusion. 10-Year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis. Khan Z, Almeida DR, Rahim K, Belliveau MJ, Bona M, Gale J. Havens SJ, Gulati V Neovascular glaucoma. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Retinal Vein Occlusions Preferred Practice Pattern. 2014 (5):CD007325įlaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. *GRADE: Grading of Recommendations Assessment, Development and Evaluation (see Sources of evidenceīraithwaite T, Nanji AA, Lindsley K, Greenberg PB. NVE and NVD likely in ischaemic occlusions)
Flame haemorrhages, dot and blot haemorrhages, cotton wool spots, hard exudates, retinal oedema, and dilated tortuous veins (signs more extensive if the occlusion is ischaemic compared to a non-ischaemic BRVO.
classically wedge-shaped retinal involvement that follows the distribution of the affected vein. risk of rubeotic glaucoma causing increased IOP and eye pain (typically after 3 months (90-day glaucoma) but can occur between 2 weeks and 2 years following RVO). new vessels elsewhere on the retina (NVE) or the disc (NVD). iris neovascularisation (rubeosis iridis) develops in approx. capillary closure and retinal hypoxia causes severe tortuosity and engorgement of branches of the central retinal vein, extensive deep blot and flame-shaped haemorrhages numerous cotton wool spots severe macular/disc oedema. 25–34% of cases non-ischaemic CRVO convert to the ischaemic subtype within 3 years. mild tortuosity and dilation of branches of the central retinal vein dot/blot and flame-shaped haemorrhages optic disc, retinal and macular oedema cotton-wool spots may be present. 75% of patients with CRVO develop macula oedema within 2 months of diagnosis and 5% to 15% with BRVO within the first yearĪ person with a CRVO has a 5% per year chance of developing a CRVO in the fellow eyeĪ person with a BRVO has a 10% risk of developing a RVO in the fellow eye over 3 yearsĪll patients with RVO are at an increased risk of future cardiovascular disease Secondary macular oedema is the most common cause of visual loss in RVO. The two main vision-threatening complications of RVO are macular oedema and retinal ischaemia, leading to poor vision, iris and retinal neovascularisation and possibly neovascular glaucoma Hemi-retinal vein occlusion (HRVO): occlusion occurring at the optic disc involving the superior or inferior hemifield and considered a mild form of CRVO with the same underlying aetiology and similar natural historyĬRVO and BRVO can be broadly classified as ischaemic or nonischaemic based on the degree of capillary non-perfusion on fluourescein angiography however, it is now known that all vein occlusions are ischaemic to varying degrees. Up to two-thirds of BRVOs occur in the superotemporal quadrant Six to seven times more common than CRVO. Branch retinal vein occlusion (BRVO): venous thrombosis occurring typically at an arteriovenous crossing, where the artery and vein share a common vascular sheath. Central retinal vein occlusion (CRVO): thrombosis of the central retinal vein at the lamina cribrosa or a retrolaminar location. RVO occurs following a complete or partial obstruction in the central retinal vein or one of its branches vasculitis or blood constituent abnormalities Other possible causes are disease of the vein wall, e.g. The most common aetiological factor is vein wall compression by adjacent atherosclerotic retinal arteries. Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy, affecting 0.77% of the global population aged 30 years or older.
0 kommentar(er)
